WASHINGTON (MedPage Today) -- Oseltamivir (Tamiflu) oral suspension will be marketed in a new 6 mg/mL concentration to reduce prescribing and dosing errors, the FDA announced Monday.
oral suspensionMore Oseltamivir Is on the WayMedPage Today Infectious Disease Sun, 12/13/2009 - 10:00
A new supply of oseltamivir (Tamiflu) for oral suspension is being shipped to wholesalers and pharmacies, which should ease the current shortage, according to the FDA. |
